NanoWattICs Establishes Working Relationship with Rosellini Scientific LLC, USA

Rosellini Scientific and NanoWattICs are developing a suite of neurostimulation devices comprising implantable, wireless and non-invasive technologies.

Rosellini Scientific, LLC (“Rosellini Scientific”; Dallas, TX, USA) and NanoWattICs SRL (“NanoWattICs”; Montevideo, UY) are pleased to formally announce their collaborative working relationship. For the past twelve months, NanoWattICs has provided support for the engineering efforts required by portfolio companies belonging to Rosellini Scientific.

Rosellini Scientific and NanoWattICs share common developmental interests and possess complementary strengths and expertise, which has produced a fruitful collaboration to date. The continuation of this long-term alliance will allow NanoWattICs to continue growing its team while participating in the development of innovative medical technologies guided by Rosellini Scientific.

“NanoWattICs are world-class engineers striving to develop the next generation of innovative medical technologies,” said Austin Duke, Director of Emerging Therapies at Rosellini Scientific. “We believe that combining their engineering expertise with the Rosellini Scientific vision will greatly enhance the process of bringing high-quality, life-changing medical technologies to the global market.”

“We are extremely pleased and excited about this collaboration opportunity with Rosellini Scientific. The combined knowledge of the two teams can hardly be matched by other players of our size in the industry,” said Pablo Aguirre, Director and Co-Founder of NanoWattICs. “We look forward to expanding our team and together bringing to market the next generation of medical devices."

Currently, Rosellini Scientific and NanoWattICs are developing a suite of neurostimulation devices comprising implantable, wireless and non-invasive technologies. This work is being supported in part by a recently awarded grant funded by Agencia Nacional de Investigación e Innovación (ANII) in Uruguay. The devices are being developed for a variety of clinical indications, including cardiac arrhythmias, migraines and neuropathic pain.

Previously, NanoWattICs provided engineering support for Rosellini Scientific to assist in the development of a non-invasive medical imaging system (Spectral MD Inc.) and wireless telemetry capabilities for a novel glaucoma implant (collaborative development with ISTAR Medical SA).

About NanoWattICs SRL
NanoWattICs SRL provides full-cycle, Integrated Circuit (IC) design services for ultra-low-power applications with a focus on medical devices. The company's rare expertise of “weak inversion/sub-threshold IC design” allows developing custom circuits that maximize battery life in portable applications. In addition, NanoWattICs’ team has extensive industrial knowledge in System Level Engineering of Active Implantable Medical Devices. This permits working with customers on Architecture definition and implementation, including Firmware and Software, on a need basis. Visit http://www.nanowattics.com to learn more.

About Rosellini Scientific, LLC
Rosellini Scientific invests both expertise and capital in the development, management and distribution of medical technology, primarily focusing on technologies that utilize electricity to alter the nervous system. The company fosters technology development through collaborations with leading researchers, as well as
partnerships with pioneering companies and universities. As a global leader in the business of technology,
Rosellini Scientific is creating an active market for translational medicine that connects buyers, sellers and inventors. Visit http://www.roselliniscientific.com to learn more.

Theme provided by Danetsoft under GPL license from Danang Probo Sayekti